Bank Pictet & Cie (Europe)’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.83M Hold
20,185
0.04% 114
2026
Q1
$1.62M Hold
20,185
0.03% 121
2025
Q4
$1.72M Buy
20,185
+1,068
+6% +$87.6K 0.03% 110
2025
Q3
$1.49M Sell
19,117
-1,789
-9% -$140K 0.03% 111
2025
Q2
$1.64M Buy
20,906
+15,004
+254% +$1.12M 0.04% 106
2025
Q1
$428K Sell
5,902
-4,329
-42% -$310K 0.01% 141
2024
Q4
$757K Buy
10,231
+1,463
+17% +$102K 0.02% 120
2024
Q3
$579K Buy
8,768
+4,068
+87% +$296K 0.01% 118
2024
Q2
$434K Hold
4,700
0.01% 125
2024
Q1
$449K Hold
4,700
0.01% 137
2023
Q4
$358K Hold
4,700
0.01% 214
2023
Q3
$326K Hold
4,700
0.01% 210
2023
Q2
$443K Sell
4,700
-3,494
-43% -$304K 0.02% 187
2023
Q1
$678K Hold
8,194
0.03% 122
2022
Q4
$611K Sell
8,194
-1,741
-18% -$134K 0.03% 115
2022
Q3
$821K Sell
9,935
-246
-2% -$23.7K 0.04% 106
2022
Q2
$968K Sell
10,181
-1,387
-12% -$144K 0.04% 99
2022
Q1
$1.36M Buy
11,568
+636
+6% +$71.3K 0.05% 96
2021
Q4
$1.42M Buy
10,932
+710
+7% +$82.8K 0.05% 99
2021
Q3
$1.16M Sell
10,222
-2,746
-21% -$313K 0.04% 100
2021
Q2
$1.34M Buy
12,968
+1,061
+9% +$100K 0.05% 99
2021
Q1
$996K Buy
+11,907
New +$1.01M 0.04% 104

Other funds holding EW

Bank Pictet & Cie (Europe)'s EW Position: Q2 2026 in Review

Bank Pictet & Cie (Europe) held its Edwards Lifesciences (EW) position steady in Q2 2026 at 20,185 shares worth $1.83M. The position accounts for 0.04% of the portfolio, ranked #114.

Bank Pictet & Cie (Europe) first reported a position in EW in Q1 2021 and has held it in 22 quarters since. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Bank Pictet & Cie (Europe) held 20,185 shares of Edwards Lifesciences worth $1.83M as of Q2 2026.
  • Bank Pictet & Cie (Europe) left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.04% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #114 holding.
  • Bank Pictet & Cie (Europe) first reported a position in Edwards Lifesciences in Q1 2021 and has held it in 22 quarters since.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.